Health

U.S. regulators approve targeted pancreatic cancer drug shown to improve survival rates

CBC 26 Aug

Canada

U.S. regulators approve targeted pancreatic cancer drug shown to improve survival rates — Sources: CBC

The U.S. Food and Drug Administration has approved Revolution Medicines' targeted drug for adults with metastatic pancreatic cancer who have received prior treatment ‌or cannot receive combination chemotherapy.

See all — CBC →

Aggregated from the leading newsrooms of the country. Every story links to its original source.

Health

See all →

As Congo Ebola deaths pass 3,000, officials seek to track spread via mobile data

CBC · 9 h

Vaccine-preventable illnesses on the horizon again as Canadian kids head back to school

CBC · 17 h

Peel, York regions confirm first human cases of West Nile virus this year

CTV News · 27 h

Hormone replacement therapy claims increase by 228 per cent in five years: Manulife

CTV News · 28 h

Clinical trial patient says ketamine treatment for bipolar depression changed his life

CTV News · 29 h

This U.K. Olympian battled porn addiction for years. He now wants to help others suffering in silence

CTV News · 30 h

Genetic discovery may lead to treatments for OCD and tics

CTV News · 31 h

Doctors, liver specialist team up to better fight hepatitis in Alberta

CBC · 31 h